Jinmei Jin

机构：Shanghai University of Traditional Chinese Medicine, Shanghai Traditional Chinese Medicine Hospital, Shuguang Hospital

发表论文 43 篇 · 总被引 1502 次 · h-index 20

代表论文

• Neutrophils as potential therapeutic targets for breast cancer (2023 · Pharmacological Research · 被引 72)
• Targeting metabolism to enhance immunotherapy within tumor microenvironment (2024 · Acta Pharmacologica Sinica · 被引 55)
• Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer (2022 · JCI Insight · 被引 53)
• Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer (2022 · Theranostics · 被引 35)
• Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells (2022 · Molecular Therapy — Oncolytics · 被引 30)
• Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming (2021 · Acta Pharmacologica Sinica · 被引 29)